Subscribe

Radnostix, Inc. (INIS)

USD0.07 +0.01 (+16.47%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address 4137 Commerce Circle 83401
Idaho Falls, ID, US
CEO Shahe Bagerdjian
IPO 1997-08-14
CIK 1038277 ISIN US45972C1027

Explore sections of this company profile

Description

Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment is responsible for creating various sources and standards essential for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging, accurate patient positioning, and for calibrating or testing the performance of dose-measuring equipment within the nuclear pharmacy industry. This segment's product range includes flood sources, dose calibrators, rod sources, flexible and rigid rulers, precision spot and pen point markers, and numerous custom-designed items. The Cobalt Products division processes bulk cobalt, fabricates cobalt capsules for use in radiation therapy and diverse industrial applications, and is involved in the recycling of depleted cobalt sources. Through its Radiochemical Products segment, Radnostix develops and supplies a variety of highly pure radiochemicals, along with the generic drug product sodium iodide I-131, serving medical, industrial, and research applications. The Radiological Services segment offers specialized services such as the safe disposal of flood sources and the intricate processing of gemstones. Finally, the Fluorine Products segment focuses on producing small-scale, high-purity fluoride gas samples for qualification in various industrial applications. It also undertakes the development of critical laboratory and analytical processes required to support a planned uranium de-conversion and fluorine extraction facility. Radnostix, Inc. distributes its products directly to end-users as well as through a network of distributors. The company was founded in 1995 and is headquartered in Idaho Falls, Idaho.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.07 +0.01 (+16.47%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
66.7K
Beta
1.20
Float Shares
106.81M
Free Float %
20.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-12.50% -21.35% -9.34% -10.49% +3.40% +14.29% +36.91% -5.47% -36.36% -12.50% -99.24%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.07
Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-11.76
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    -6.0% Q1'26: -26.6% (vs Q1'25)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    Q1'26: -1,200.0% (vs Q1'25)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    +0.1% Q1'26: -11.7% (vs Q1'25)
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -4.4% Q1'26: -55.1% (vs Q1'25)
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    +0.0% Q1'26: -87.0% (vs Q1'25)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +0.9% Q1'26: +0.8% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    Q1'26: -0.90× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.10) × ERP
WACC = 0% × Ke + 100% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.07
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-69.15B
OE per share TTM
-130.82
Owner's Yield
-174,459.82%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
8,336,664.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1
Total invested
1.2K
Insider transactions (90d)
0
Beneficial owners (>5%)
8
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Kennerman Associates, Inc. d/b/a Kershner Grosso & Co. 230.26M 43.96% 230.26M IA New York 2021-04-30
2 Christopher Grosso 60.77M 11.76% 57.24M 3.53M 5.00M 52.24M IA OR PLACE OF ORGANIZATION 2022-05-02
3 James J. Keane 17.58M 6.00% 1.84M 15.74M 1.84M 10.00 CO United States of America 2010-05-13
4 Marie C. Keane 15.74M 5.30% 15.74M 10.00 CO United States of America 2010-05-13
5 Thomas Kershner 8.15M 1.80% 8.15M 8.15M IA New York 2021-04-30
6 DKR MANAGEMENT COMPANY, INC. 1.92M 10.00% 1.92M 1.92M CO Delaware 2002-02-15
7 Fort Worth, TX 76102 325.5K 3.10% 2.0K 225.0K IA Fort Worth, Texas 2001-02-13
8 Debello Investors LLC 8.1K 0.11% 95.43M OO New York 2008-06-09

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q4
Investors holding
1
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 CAPITAL SQUARE, LLC 20.0K +— (+0.0%) 1.2K +64.0 (+5.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.03 +100.0% 24 qtrs
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
591.1K
Shares disposed
Cash buys
4.00
Cash sales
Net activity
+591,117
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2025-10-10 Laflin Steve Director A-Award A Stock Option (Right to Buy) 500,000 0.06 30.0K 500,000 D
2025-10-10 GROSSO CHRISTOPHER G Director / 10% Owner A-Award A Stock Option (Right to Buy) 500,000 0.06 30.0K 500,000 D
2025-10-10 Atcher Robert Director A-Award A Common Stock 250,000 0.00 1,000,000 D
2025-10-09 Bagerdjian Shahe Director / Officer A-Award A Restricted Stock Units 37,500,000 0.00 37,500,000 D
2025-05-22 Bagerdjian Shahe Director / Officer P-Purchase A Common Stock 140,000 0.05 7.0K 9,026,999 D
2025-04-24 Bagerdjian Shahe Director / Officer F-InKind D Common Stock 583,229 0.05 29.2K 8,886,999 D
2025-03-06 Bagerdjian Shahe Director / Officer P-Purchase A Common Stock 177,000 0.05 8.9K 9,570,228 D
2025-02-17 GROSSO CHRISTOPHER G Director / 10% Owner J-Other A Common Stock 269,999 0.00 38,477,083 D
2024-11-22 COX W MATTHEW Officer P-Purchase A Common Stock 60,000 0.03 1.8K 897,736 D
2024-11-20 COX W MATTHEW Officer P-Purchase A Common Stock 30,000 0.04 1.2K 837,736 D
2024-11-20 Bagerdjian Shahe Director / Officer P-Purchase A Common Stock 100,000 0.04 4.0K 9,393,228 D
2024-11-14 GROSSO CHRISTOPHER G Director P-Purchase A Common Stock 401,117 0.03 12.0K 1,026,283 I
2024-10-30 GROSSO CHRISTOPHER G Director A-Award A Stock Option (Right to Buy) 1,500,000 0.04 52.5K 1,500,000 D
2024-09-18 GROSSO CHRISTOPHER G Director P-Purchase A Common Stock 500,000 0.03 15.0K 38,707,084 D
2024-09-13 Bagerdjian Shahe Director / Officer A-Award A Common Stock 350,000 0.00 9,293,228
2024-06-14 COX W MATTHEW Officer P-Purchase A Common Stock 239,669 0.04 9.6K 807,736
2024-06-14 Bagerdjian Shahe Director / Officer P-Purchase A Common Stock 250,000 0.04 10.0K 8,943,228
2024-04-17 Bagerdjian Shahe Director / Officer F-InKind D Common Stock 531,750 0.04 21.3K 8,693,228
2024-02-17 GROSSO CHRISTOPHER G Director J-Other A Common Stock 240,000 0.00 11,451,129 I
2023-12-14 COX W MATTHEW Officer P-Purchase A Common Stock 250,000 0.03 6.3K 538,925
2023-12-14 Bagerdjian Shahe Director / Officer P-Purchase A Common Stock 1,000,000 0.03 25.0K 9,224,978
2023-09-05 Bagerdjian Shahe Director / Officer A-Award A Common Stock 2,500,000 0.00 9,003,950
2023-08-25 Bagerdjian Shahe Director / Officer P-Purchase A Common Stock 3,950 0.05 197.50 6,503,950
2023-05-10 Bagerdjian Shahe Officer A-Award A Common Stock 6,500,000 0.00 6,500,000
2023-05-08 Bagerdjian Shahe Officer 0 0.00 0
2023-03-03 Atcher Robert Director A-Award A Common Stock 750,000 0.00 750,000
2023-02-28 Laflin Steve Director / Officer A-Award A Common Stock 560,000 0.00 9,759,606
2022-11-15 GROSSO CHRISTOPHER G Director P-Purchase A Common Stock 1,410,000 0.03 42.3K 10,911,129
2022-03-16 Laflin Steve Director / Officer M-Exempt D Stock Option (Right to Buy) 1,000,000 0.04 35.0K 1,000,000
2022-02-28 Laflin Steve Director / Officer A-Award A Common Stock 307,692 0.00 8,708,956
2022-02-21 Laflin Steve Director / Officer A-Award A Stock Option (Right to Buy) 2,000,000 0.09 180.0K 2,000,000
2022-02-21 GROSSO CHRISTOPHER G Director A-Award A Stock Option (Right to Buy) 2,000,000 0.09 180.0K 2,000,000
2022-02-21 COX W MATTHEW Officer A-Award A Stock Option (Right to Buy) 1,000,000 0.09 90.0K 1,000,000
2022-02-21 Atcher Robert Director A-Award A Stock Option (Right to Buy) 2,000,000 0.09 180.0K 2,000,000
2021-02-28 Laflin Steve Director / Officer F-InKind D Common Stock 77,489 0.14 11.1K 8,401,264
2021-01-20 RICHART RALPH M 10% Owner F-InKind D Common Stock 3,075,537 0.28 861.2K 88,660,930
2021-01-20 Laflin Steve Director / Officer M-Exempt D Class O Warrants (Right to Buy) 750,000 0.05 33.8K 0
2021-01-20 GROSSO CHRISTOPHER G Director M-Exempt D Class M Warrants (Right to Buy) 175,000 0.12 21.0K 0
2021-01-20 COX W MATTHEW Officer F-InKind D Common Stock 13,393 0.28 3.8K 49,107
2020-08-19 Laflin Steve Director / Officer M-Exempt A Common Stock 1,000,000 0.04 35.0K 8,665,682
2020-02-28 Laflin Steve Director / Officer A-Award A Common Stock 500,000 0.00 6,101,360
2019-12-30 RICHART RALPH M 10% Owner P-Purchase A Class O Warrants (Right to Buy) 9,750,000 0.05 438.8K 9,750,000
2019-12-30 Laflin Steve Director / Officer P-Purchase A Class O Warrants (Right to Buy) 750,000 0.05 33.8K 750,000
2019-12-30 GROSSO CHRISTOPHER G Director P-Purchase A Class O Warrants (Right to Buy) 9,750,000 0.05 438.8K 9,750,000
2019-09-23 COX W MATTHEW Officer D Stock Option (Right to Buy) 250,000 0.06 15.0K 0
2019-04-25 GROSSO CHRISTOPHER G Director M-Exempt A Common Stock 2,000,000 0.04 70.0K 23,360,925
2019-04-22 McKenzie-Carter Laurie Officer M-Exempt A Common Stock 500,000 0.04 17.5K 1,035,443
2019-04-22 Laflin Steve Director / Officer M-Exempt A Common Stock 1,000,000 0.04 35.0K 6,184,693
2019-02-28 Laflin Steve Director / Officer F-InKind D Common Stock 186,900 0.06 11.2K 5,184,693
2019-02-17 RICHART RALPH M 10% Owner J-Other A Common Stock 704,000 0.00 78,466,467
2019-02-17 GROSSO CHRISTOPHER G Director J-Other A Common Stock 35,000 0.00 58,333
2018-07-27 RICHART RALPH M 10% Owner M-Exempt A Common Stock 1,500,000 0.04 52.5K 78,108,621
2018-04-20 RICHART RALPH M 10% Owner M-Exempt A Common Stock 2,000,000 0.04 70.0K 76,608,621
2018-02-28 Laflin Steve Director / Officer A-Award A Common Stock 350,000 0.00 5,045,101
2018-02-17 RICHART RALPH M 10% Owner J-Other A Common Stock 469,332 0.00 74,608,621
2018-02-17 GROSSO CHRISTOPHER G Director J-Other A Common Stock 155,999 0.00 21,126,925
2018-01-08 Laflin Steve Director / Officer M-Exempt D Stock Option (Right to Buy) 1,000,000 0.04 35.0K 1,000,000
2017-08-02 Atcher Robert Director A-Award A Stock Option (Right to Buy) 1,000,000 0.08 80.0K 1,000,000
2017-07-11 McKenzie-Carter Laurie Officer A-Award A Stock Option (Right to Buy) 1,000,000 0.06 60.0K 1,000,000
2017-07-11 Laflin Steve Director / Officer A-Award A Stock Option (Right to Buy) 4,000,000 0.06 240.0K 4,000,000
2017-07-11 GROSSO CHRISTOPHER G Director A-Award A Stock Option (Right to Buy) 2,000,000 0.06 120.0K 2,000,000
2017-03-20 Laflin Steve Director / Officer M-Exempt A Common Stock 1,000,000 0.04 35.0K 4,583,990
2017-03-13 McKenzie-Carter Laurie Officer F-InKind D Common Stock 250,000 0.07 17.5K 535,443
2017-02-28 Laflin Steve Director / Officer F-InKind D Common Stock 140,175 0.08 11.2K 3,583,990
2017-02-17 RICHART RALPH M Director / 10% Owner P-Purchase A Series C Convertible Redeemable Preferred Stock 704 0.10 70.40 704
2017-02-17 GROSSO CHRISTOPHER G Director P-Purchase A Series C Convertible Redeemable Preferred Stock 234 0.10 23.40 234
2016-08-15 RICHART RALPH M Director / 10% Owner F-InKind D Common Stock 875,000 0.08 70.0K 74,139,289
2016-08-15 GROSSO CHRISTOPHER G Director M-Exempt A Common Stock 2,000,000 0.04 70.0K 21,845,926
2016-05-23 McKenzie-Carter Laurie Officer M-Exempt D Stock Option (Right to Buy) 500,000 0.04 17.5K 500,000
2016-02-29 Laflin Steve Director / Officer A-Award A Common Stock 280,000 0.00 3,486,305
2015-03-06 GROSSO CHRISTOPHER G Director P-Purchase A Common Stock 1,766,667 0.02 39.8K 19,845,926
2015-02-28 Laflin Steve Director / Officer A-Award A Common Stock 167,860 0.00 3,206,305
2015-02-20 RICHART RALPH M Director / 10% Owner C-Conversion D Convertible Debentures due 2015 2,142,858 0.04 85.7K 0
2015-02-20 GROSSO CHRISTOPHER G Director C-Conversion D Convertible Debentures due 2015 357,143 0.04 14.3K 0
2014-10-27 RICHART RALPH M Director / 10% Owner D-Return D Stock Option (Right to Buy) 2,000,000 0.08 160.0K 0
2014-10-27 McKenzie-Carter Laurie Officer D-Return D Stock Option (Right to Buy) 1,000,000 0.07 70.0K 0
2014-10-27 Laflin Steve Director / Officer D-Return D Stock Option (Right to Buy) 3,000,000 0.07 210.0K 0
2014-10-27 GROSSO CHRISTOPHER G Director A-Award A Stock Option (Right to Buy) 1,500,000 0.04 52.5K 1,500,000
2014-06-30 RICHART RALPH M Director / 10% Owner A-Award A Warrant (Right to Buy) 12,500,000 0.06 750.0K 12,500,000
2014-06-30 MCCORMACK JOHN M 10% Owner A-Award A Warrant (Right to Buy) 12,500,000 0.06 750.0K 12,500,000
2014-02-28 Laflin Steve Director / Officer A-Award A Common Stock 167,860 0.00 3,038,445
2013-12-23 RICHART RALPH M Director / 10% Owner A-Award A Warrant (Right to Buy) 5,000,000 0.06 300.0K 5,000,000
2013-12-23 MCCORMACK JOHN M 10% Owner A-Award A Warrant (Right to Buy) 5,000,000 0.06 300.0K 5,000,000
2013-12-13 RICHART RALPH M Director / 10% Owner P-Purchase A Common Stock 4,000,000 0.02 90.0K 63,939,289
2013-12-13 MCCORMACK JOHN M 10% Owner P-Purchase A Common Stock 13,824,981 0.02 311.1K 17,616,649
2013-12-13 GROSSO CHRISTOPHER G Director P-Purchase A Common Stock 4,000,000 0.02 90.0K 16,566,759
2013-11-11 RICHART RALPH M Director / 10% Owner A-Award A Stock Option (Right to Buy) 2,000,000 0.07 140.0K 2,000,000
2013-11-11 McKenzie-Carter Laurie Officer A-Award A Stock Option (Right to Buy) 1,000,000 0.07 70.0K 1,000,000
2013-11-11 Laflin Steve Director / Officer A-Award A Stock Option (Right to Buy) 3,000,000 0.07 210.0K 3,000,000
2013-11-11 GROSSO CHRISTOPHER G Director D-Return D Stock Option (Right to Buy) 1,000,000 0.17 170.0K 0
2013-04-05 RICHART RALPH M Director / 10% Owner M-Exempt A Common Stock 1,000,000 0.03 30.0K 60,042,737
2013-04-05 GROSSO CHRISTOPHER G Director M-Exempt A Common Stock 1,000,000 0.03 30.0K 12,670,207
2013-02-28 Laflin Steve Director / Officer A-Award A Common Stock 104,912 0.00 2,870,585
2013-02-20 RICHART RALPH M Director / 10% Owner P-Purchase A Convertible Debentures due 2015 2,142,858 0.14 300.0K 2,142,858
2013-02-20 GROSSO CHRISTOPHER G Director P-Purchase A Convertible Debentures due 2015 357,143 0.14 50.0K 357,143
2012-12-31 RICHART RALPH M Director / 10% Owner I Common Stock 0 0.00 1,374,866
2012-12-31 GROSSO CHRISTOPHER G Director I Common Stock 0 0.00 10,000
2012-09-26 RICHART RALPH M Director / 10% Owner A-Award A Stock Option (Right to Buy) 1,000,000 0.17 170.0K 1,000,000
2012-09-26 McKenzie-Carter Laurie Officer D-Return D Stock Option (Right to Buy) 500,000 0.32 160.0K 0
2012-09-26 GROSSO CHRISTOPHER G Director A-Award A Stock Option (Right to Buy) 1,000,000 0.17 170.0K 1,000,000
2012-01-31 Laflin Steve Director / Officer M-Exempt D Stock Option (Right to Buy) 1,000,000 0.02 20.0K 7,500,000
2011-08-24 RICHART RALPH M Director / 10% Owner C-Conversion A Common Stock 883,334 0.19 167.8K 67,142,730
2011-08-24 MCCORMACK JOHN M 10% Owner C-Conversion A Common Stock 3,091,668 0.19 587.4K 3,791,668
2011-04-22 Laflin Steve Director / Officer F-InKind D Common Stock 648,737 0.17 110.3K 1,765,673
2010-02-24 RICHART RALPH M Director / 10% Owner P-Purchase A 6% Convertible Debentures due 2011 428,571 0.35 150.0K 428,571
2010-02-24 MCCORMACK JOHN M 10% Owner P-Purchase A 6% Convertible Debentures due 2011 1,500,000 0.35 525.0K 1,500,000
2009-09-18 RICHART RALPH M Director / 10% Owner A-Award A Class G Warrants (Right to Buy) 416,667 0.40 166.7K 416,667
2009-09-18 MCCORMACK JOHN M 10% Owner A-Award A Class G Warrants (Right to Buy) 300,000 0.40 120.0K 300,000
2009-09-18 GROSSO CHRISTOPHER G Director A-Award A Class G Warrants (Right to Buy) 83,333 0.40 33.3K 83,333
2009-05-04 RICHART RALPH M Director / 10% Owner A-Award A Stock Option (Right to Buy) 2,000,000 0.32 640.0K 2,000,000
2009-05-04 McKenzie-Carter Laurie Officer A-Award A Stock Option (Right to Buy) 500,000 0.32 160.0K 500,000
2009-05-04 Laflin Steve Director / Officer A-Award A Stock Option (Right to Buy) 3,000,000 0.32 960.0K 3,000,000
2009-05-04 GROSSO CHRISTOPHER G Director A-Award A Stock Option (Right to Buy) 2,000,000 0.32 640.0K 2,000,000
2008-11-07 RICHART RALPH M Director / 10% Owner A-Award A Class F Warrants (Right to Buy) 400,000 0.30 120.0K 400,000
2008-11-07 MCCORMACK JOHN M 10% Owner A-Award A Class F Warrants (Right to Buy) 400,000 0.25 100.0K 400,000
2008-11-07 GROSSO CHRISTOPHER G Director A-Award A Class F Warrants (Right to Buy) 100,000 0.30 30.0K 100,000
2008-04-14 RICHART RALPH M Director / 10% Owner X-InTheMoney A Common Stock 5,277,777 0.10 527.8K 65,442,729
2008-04-14 GROSSO CHRISTOPHER G Director X-InTheMoney A Common Stock 277,777 0.10 27.8K 5,192,190
2008-04-09 RICHART RALPH M Director / 10% Owner J-Other A Class E Warrants (Right to Buy) 5,277,777 0.87 4.59M 5,277,777
2008-04-09 GROSSO CHRISTOPHER G Director J-Other A Class E Warrants (Right to Buy) 277,777 0.87 241.4K 277,777
2008-01-09 RICHART RALPH M Director / 10% Owner X-InTheMoney A Common Stock 5,277,777 0.11 580.6K 60,164,952
2008-01-08 GROSSO CHRISTOPHER G Director X-InTheMoney A Common Stock 277,777 0.11 30.6K 4,914,413
2007-10-31 McKenzie-Carter Laurie Officer 0 0.00 0
2007-08-08 Laflin Steve Director / Officer M-Exempt A Common Stock 1,500,000 0.02 30.0K 1,500,125
2007-06-08 NICHOLSON WILLIAM W 10% Owner X-InTheMoney A Common Stock 1,057,164 0.05 52.9K 21,440,004
2007-04-23 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner P-Purchase A Class Z Warrants 189,000 0.00 189,000
2007-04-02 RICHART RALPH M Director / 10% Owner C-Conversion D 6% Convertible Promissory Note 1,950,000 0.08 156.0K 0
2007-04-02 OHEARN WALTER D C-Conversion A Common Stock 945,650 0.08 75.7K 16,270,329
2007-04-02 NICHOLSON WILLIAM W 10% Owner C-Conversion A Common Stock 1,690,511 0.08 135.2K 20,382,840
2007-04-02 MCCORMACK JOHN M 10% Owner C-Conversion A Common Stock 2,105,043 0.08 168.4K 29,814,808
2007-04-02 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner C-Conversion A Common Stock 945,650 0.08 75.7K 16,426,629
2007-04-02 GROSSO CHRISTOPHER G Director / 10% Owner C-Conversion D 6% Convertible Promissory Note 325,000 0.08 26.0K 0
2007-03-21 RICHART RALPH M Director / 10% Owner P-Purchase A Class D Warrants (Right to Buy) 5,277,777 0.11 580.6K 5,277,777
2007-03-21 GROSSO CHRISTOPHER G Director / 10% Owner P-Purchase A Class C Warrants (Right to Buy) 277,777 0.10 27.8K 277,777
2006-08-15 RICHART RALPH M Director / 10% Owner A-Award A Stock Option (Right to Buy) 2,000,000 0.08 160.0K 2,000,000
2006-08-15 GROSSO CHRISTOPHER G Director / 10% Owner A-Award A Stock Option (Right to Buy) 2,000,000 0.08 160.0K 2,000,000
2006-02-03 RICHART RALPH M Director / 10% Owner X-InTheMoney D Warrant (Right to Buy) 4,000,000 0.05 200.0K 7
2005-12-30 RICHART RALPH M Director / 10% Owner J-Other A 6% Convertible Promissory Note 1,950,000 0.08 156.0K 1,950,000
2005-12-30 OHEARN WALTER D J-Other A 6% Convertible Promissory Note 912,500 0.08 73.0K 912,500
2005-12-30 NICHOLSON WILLIAM W 10% Owner J-Other A 6% Convertible Promissory Note 1,631,250 0.08 130.5K 1,631,250
2005-12-30 MCCORMACK JOHN M 10% Owner J-Other A 6% Convertible Promissory Note 2,031,250 0.08 162.5K 2,031,250
2005-12-30 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner J-Other A 6% Convertible Promissory Note 912,500 0.08 73.0K 912,500
2005-12-30 GROSSO CHRISTOPHER G Director / 10% Owner J-Other A 6% Convertible Promissory Note 325,000 0.08 26.0K 325,000
2005-11-23 NICHOLSON WILLIAM W 10% Owner X-InTheMoney A Common Stock 1,659,840 0.05 83.0K 18,692,329
2005-11-11 NICHOLSON WILLIAM W 10% Owner X-InTheMoney A Common Stock 700,000 0.05 35.0K 17,032,489
2005-11-10 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner X-InTheMoney D Warrant (Right to Buy) 1,000,000 0.05 50.0K 772,706
2005-10-28 MCCORMACK JOHN M 10% Owner X-InTheMoney D Warrant (Right to Buy) 2,928,744 0.05 146.4K 1,456,416
2005-09-27 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner P-Purchase A Common Stock 200,000 0.06 12.0K 12,708,273
2005-09-14 OHEARN WALTER D X-InTheMoney A Common Stock 1,136,000 0.05 56.8K 13,561,373
2005-08-16 RICHART RALPH M Director / 10% Owner X-InTheMoney A Common Stock 8,441,760 0.05 422.1K 43,588,557
2005-07-19 RICHARD RALPH M Director / 10% Owner P-Purchase A Common Stock 100,000 0.08 8.1K 35,146,797
2005-07-18 OHEARN WALTER D P-Purchase A Common Stock 100,000 0.08 8.0K 12,425,373
2005-07-18 MCCORMACK JOHN M 10% Owner P-Purchase A Common Stock 100,000 0.08 8.0K 24,224,962
2005-07-15 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner P-Purchase A Common Stock 150,000 0.08 12.0K 12,508,273
2003-09-21 OHEARN WALTER D 10% Owner C-Conversion A Series B Warrant 1,763,306 0.05 88.2K 1,763,306
2003-09-21 KEANE MARIE C & KEANE JAMES JTWROS 10% Owner C-Conversion A Common Stock 1,772,706 0.03 53.2K 12,358,273

Executive team

Top executives
EBIT / Employee
-13.9K
Shares Outstanding
529.13M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2024 Shahe Bagerdjian President, Chief Executive Officer 294.6K 64.5K 70.5K 120.00 429.7K 16.41%
2 2024 W. Matthew Cox Chief Financial Officer and Secretary 147.4K 379.00 712.00 118.00 148.7K 0.48%
3 2023 Steve. T. Laflin Former Chief Executive Officer 184.1K 106.5K 22.4K 65.6K 378.6K 5.92%
4 2023 Shahe Bagerdjian President, Chief Executive Officer 191.0K 2.0K 150.0K 24.3K 367.3K 40.84%
5 2023 W. Matthew Cox Chief Financial Officer and Secretary 138.5K 7.6K 13.1K 107.00 159.3K 8.22%
6 2023 Matthew Cox Chief Financial Officer and Secretary 138.5K 7.6K 13.1K 107.00 159.3K 8.22%
7 2022 Steve. T. Laflin Chief Executive Officer 249.1K 27.7K 105.0K 112.1K 493.9K 26.87%
8 2022 Steve. T. Laflin Former Chief Executive Officer 249.1K 27.7K 105.0K 112.1K 493.9K 26.87%
9 2022 Matthew Cox Chief Financial Officer and Secretary 131.4K 5.4K 54.2K 89.00 191.1K 28.35%
10 2021 Steve. T. Laflin Chief Executive Officer 244.1K 23.5K 113.6K 381.2K 6.16%
11 2021 Steve. T. Laflin President and Chief Executive Officer 244.1K 23.5K 113.6K 381.2K 6.16%
12 2021 Matthew Cox Chief Financial Officer and Secretary 124.3K 13.2K 80.00 137.6K 9.61%
13 2020 Steve. T. Laflin President and Chief Executive Officer 248.2K 30.0K 112.4K 390.6K 7.68%
14 2020 Matthew Cox Chief Financial Officer and Secretary 127.4K 76.00 127.4K 0.00%
15 2019 Steve. T. Laflin President and Chief Executive Officer 234.0K 28.0K 112.7K 374.7K 7.47%
16 2019 Laurie McKenzie-Carter Former Chief Financial Officer and Secretary 109.4K 618.00 110.0K 0.00%
17 2019 Matthew Cox Chief Financial Officer and Secretary 73.5K 8.7K 40.00 82.3K 10.58%
18 2018 Steve. T. Laflin President and Chief Executive Officer 229.0K 28.0K 113.7K 370.7K 7.55%
19 2018 Laurie McKenzie-Carter Former Chief Financial Officer and Secretary 118.9K 4.3K 618.00 123.8K 0.00%
20 2018 Laurie McKenzie-Carter Chief Financial Officer and Secretary 118.9K 4.3K 618.00 123.8K 0.00%
21 2017 Steve. T. Laflin President and Chief Executive Officer 224.0K 27.5K 28.0K 115.9K 113.3K 508.7K 28.29%
22 2017 Laurie McKenzie-Carter Chief Financial Officer and Secretary 119.2K 4.0K 37.4K 550.00 161.2K 23.22%
23 2017 Laurie McKenzie-Carter Chief Financial Officer 119.2K 4.0K 37.4K 550.00 161.2K 23.22%
24 2016 Steve T. Laflin President and CEO 219.0K 25.0K 15.1K 113.8K 372.9K 4.05%
25 2016 Steve. T. Laflin President and Chief Executive Officer 219.0K 25.0K 15.1K 113.8K 361.9K 4.17%
26 2016 Laurie McKenzie-Carter Chief Financial Officer 113.7K 11.6K 523.00 125.8K 0.00%
27 2015 Steve T. Laflin President and CEO 215.0K 20.0K 14.0K 112.9K 361.9K 3.87%
28 2015 Laurie McKenzie-Carter Chief Financial Officer 107.7K 4.0K 315.00 112.0K 0.00%
29 2014 Steve T. Laflin President and CEO 209.1K 16.8K 82.8K 113.1K 421.8K 23.61%
30 2014 Steve T. Laflin President and CEO 209.1K 16.8K 82.8K 113.1K 421.8K 23.61%
31 2014 Laurie McKenzie-Carter Chief Financial Officer 104.1K 30.2K 134.3K 22.48%
32 2014 Laurie McKenzie-Carter Chief Financial Officer 104.1K 30.2K 134.3K 22.48%
33 2013 Steve T. Laflin President and CEO 205.0K 28.0K 60.6K 112.4K 406.0K 21.83%
34 2013 Laurie McKenzie-Carter Chief Financial Officer 104.1K 37.1K 141.2K 26.29%
35 2012 Steve T. Laflin President and CEO 200.0K 108.8K 308.8K 0.00%
36 2012 Laurie McKenzie-Carter Chief Financial Officer 96.0K 6.0K 8.0K 110.0K 7.29%
37 2011 Steve T. Laflin President and CEO 185.0K 10.0K 195.0K 0.00%
38 2011 Laurie McKenzie-Carter CFO 96.0K 5.0K 101.0K 0.00%
39 2011 Laurie McKenzie-Carter Chief Financial Officer 96.0K 5.0K 101.0K 0.00%
40 2010 Steve T. Laflin President and CEO 185.0K 37.5K 222.5K 0.00%
41 2010 Laurie McKenzie-Carter CFO 91.8K 7.5K 99.3K 0.00%
42 2009 Steve T. Laflin President and CEO 170.5K 35.0K 701.5K 907.0K 77.34%
43 2009 Laurie McKenzie-Carter CFO 85.8K 7.5K 116.9K 210.3K 55.61%
44 2008 Steve T. Laflin President and CEO 166.1K 30.0K 196.1K 0.00%
45 2008 Laurie McKenzie-Carter CFO 67.5K 10.0K 77.5K 0.00%
46 2007 Laurie McKenzie-Carter CFO 57.2K 750.00 594.3K 652.2K 91.12%
47 2007 Steve T. Laflin President and CEO 160.0K 25.0K 185.0K 0.00%
48 2006 Steve T. Laflin President and CEO 145.1K 15.0K 164.6K 0.00%
49 2006 Laurie McKenzie-Carter CFO
50 2005 Steve T. Laflin President Chief Executive Officer 131.3K 22.0K 153.3K 0.00%
51 2004 Steve T. Laflin President Chief Executive Officer 128.3K 12.0K 140.3K 0.00%
52 2003 Steve T. Laflin President Chief Executive Officer 125.0K 10.0K 10.00M 135.0K 7,407.41%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-05-27 DEFA14A
2025-05-27 DEF 14A
2025-05-16 PRE 14A
2024-05-21 DEF 14A
2024-04-29 DEF 14A
2023-05-24 DEFA14A
2023-05-24 DEF 14A
2022-05-20 DEFA14A
2022-05-02 DEF 14A
2021-04-30 DEF 14A
2020-04-29 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-30 4
2026-04-30 10-K/A
2026-03-31 10-K
2026-03-16 8-K
2025-12-31 8-K
2025-11-26 DEF 14C
2025-11-14 10-Q
2025-10-17 8-K
2025-10-17 8-K
2025-10-15 4

Executive team

NameTitleCompensationGender
Shahe Bagerdjian President,Chief Executive Officer & Director 364.3K male
W. Matthew Cox Chief Financial Officer & Secretary 147.9K male
ESG Rating
B
DRUG MANUFACTURERS - SPECIALTY & GENERIC
2014
E (Environmental)
76.3 / 66.0
Company / Sector avg.
S (Social)
70.0 / 70.0
Company / Sector avg.
G (Governance)
73.5 / 66.6
Company / Sector avg.
ESG Total
73.3 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits